ArticleThe Journal of biological chemistry2026
Highly branched complex-type N-glycans on integrin β1 in extracellular vesicles enhance the binding of sEVs to laminin on recipient cells.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small extracellular vesicles (sEVs) play a crucial role in intercellular communication. Recently, we discovered that sEVs bind to recipient cells via interactions between integrin heterodimers and laminins. In this study, we explored how sEV-associated glycans regulate this binding. We performed glycomic analyses of asparagine-linked (N-linked) glycans on integrin β1 in tumor-derived sEVs, revealing that N-glycan structures in sEVs differ from those in their cells of origin. Highly branched, complex-type N-glycans on integrin β1 were predominant in sEVs, whereas less branched complex-type and oligomannose-type N-glycans were more abundant in cells. Furthermore, the sialic acid content of sEV N-glycans was higher than that of cellular glycans. Simultaneous single-particle imaging and super-resolution movie observation revealed that knocking out the glycosyltransferase MGAT5, which synthesizes highly branched complex-type N-glycans, reduced the binding ability of tumor-derived sEVs to laminin on both glass and recipient cell membranes. Although α2,3-sialidase treatment of sEVs did not alter their laminin-binding ability, the α2-3,6,8 sialidase treatment and KO of ST6GAL1 significantly decreased it. Observations following the removal of the N-glycan from the I-like domain of integrin β1 via an NQ mutation revealed that the glycan at N269 enhances binding. Additionally, an antibody against the activated state of integrin β1 bound more frequently to WT integrin β1 in sEVs than to the N269Q mutant, indicating that the glycan at N269 is essential for maintaining the protein's activated conformation. Thus, using advanced imaging techniques, we elucidated the regulatory mechanisms by which N-glycans control the binding of sEVs to laminin on recipient cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.